CME Group oversold on regulatory litigation risk
The bullish case argued for CME Group: recent sell-off created an attractive entry point as the exchange defends its core institutional hedging business through litigation against CFTC's perpetual futures decisions.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.